Recently, our lab reported that by splitting the CAR construct into two parts (split GPC-3 CAR-T cells), HCC tumors could be eliminated with a decreased amount of proinflammatory cytokines (71). The gene discussed is GPC3; the disease is hepatocellular carcinoma.